Headshot of Dr Tanzeel Janjua

Dr Tanzeel Janjua

Dr Tanzeel Janjua
MBBS, MRCP, FRCP, CCT Clinical Oncology, Consultant Clinical Oncologist

Languages spoken


Expert in

Lung Cancer and Urological Cancers


Dr Janjua is currently a Consultant in Clinical Oncology at St. James University Hospital, Leeds, UK. He completed his specialist training and achieved the CCT in Clinical Oncology in Jan 2021 from Leeds Cancer Centre.

Dr Janjua has a special interest in management of Lung and Urology cancers. He is competent in treating patients with Radiotherapy advanced techniques including Stereotactic ablative radiotherapy (SABR), Image Guided Radiotherapy (IMRT), Volumetric modulated arc therapy (VMAT), Ultra-Hypo fractionated Radiotherapy and systemic treatments including chemotherapy, immunotherapy and targeted therapy.

Dr Janjua maintains an active involvement in teaching and training at undergraduate and post graduate level. He is actively involved in clinic research, risk management and clinical governance and have taken up various management roles. Dr Janjua has also published research papers in peer-reviewed Journals.

Career Positions

Current position(s)

  • Consultant in Clinical Oncology at St. James University Hospital, Leeds

Expertise and interests

  • Lung SABR
  • Prostate SABR
  • Chemo-immunotherapy

Professional associations

  • British thoracic oncology group
  • Royal college of Radiologists

Research and Publications

1. Efficacy and toxicity hypo-fractionated radiotherapy for centrally located non-small cell lung cancer. Journal of Radiotherapy in Practice, Volume 22, 2023, e5.

2. Palliative radiotherapy in bladder cancer – importance of patient selection: A retrospective multicentre study. International Journal of Radiation: Oncology - Biology - Physics

3. Crystal structure and antimicrobial activity of a transplatin adduct of N, N0-dimethylthiourea, trans-[Pt(NH3)2(dmtu)2]Cl2. An International Journal of Chemistry Volume 148: 669-674

4. Stereotactic ablative radiotherapy for multiple lung metastases: a single centre experience.
SABR Consortium 2019 Conference, Harrogate, UK.

5. The Role of Palliative Re-irradiation in Management of Rectal Cancer. ESMO world GI conference 2018.